Pedi-Biotic
Natural health product licensed in Canada
- Other names
- MJ NUTRA Probiotiques pour enfants
- Licence holder
- Virage Santé Inc.
- NPN or DIN-HM
- 80012363
- Status
- Active licence
- Licence date
- 7 August 2009
- Revision date
- 16 December 2024
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : LAC-361 | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium infantis Source : M-63 | 0.5 Milliards d'UFC | Not calculated |
| Bifidobacterium longum Source : BB-536 | 0.7 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Maltodextrine, Arabinogalactane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 1 year | 0.5 Cuillère à thé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Ce probiotique exerce un effet bénéfique pour la santé.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
L'arabinogalactan pris à raison de 30 g par jour peut provoquer des ballonnement dans 3% des cas. Mais la dose recommandée est loin de cette valeur.
- Contre-indications
Ne pas utiliser si vous souffrez de nausées, de la fièvre, de vomissements, de diarrhée sanglante ou de douleurs abdominales intenses. Ne pas utiliser si vous souffrez d'un déficit immunitaire (e.g. sida, lymphone, patients subissant un traitement prolongé aux corticostéroïdes).
Source
Official Health Canada record, licence 80012363
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.